Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Laurence Van Overtvelt
Affiliation
Universite Libre de Bruxelles
ORCID
Career Start Year
1999
Papers
30
H Index
23
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
21961022
Lactococcus lactis NCC 2287 alleviates food allergic manifestations in sensitized mice by reducing IL-13 expression specifically in the ileum.
Clin Dev Immunol
2012
22205338
Bifidobacterium bifidum NCC 453 promotes tolerance induction in murine models of sublingual immunotherapy.
Int Arch Allergy Immunol
2012
21105918
Distinct characteristics of seasonal (Bet v 1) vs. perennial (Der p 1/Der p 2) allergen-specific CD4(+) T cell responses.
Clin Exp Allergy
2011
21775981
Oral macrophage-like cells play a key role in tolerance induction following sublingual immunotherapy of asthmatic mice.
Mucosal Immunol
2011
21883279
Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy.
Allergy
2011
21562971
Induction of allergen-specific tolerance via mucosal routes.
Curr Top Microbiol Immunol
2011
21368225
Identification of a new phenotype of tolerogenic human dendritic cells induced by fungal proteases from Aspergillus oryzae.
J Immunol
2011
21418343
Comparison between major histocompatibility complex class II tetramer staining and surface expression of activation markers for the detection of allergen-specific CD4⺠T cells.
Clin Exp Allergy
2011
20407270
Recombinant fusion proteins assembling Der p 1 and Der p 2 allergens from Dermatophagoides pteronyssinus.
Int Arch Allergy Immunol
2010
20175969
Lactic acid bacteria as adjuvants for sublingual allergy vaccines.
Vaccine
2010
19220212
Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction.
Allergy
2009
19694757
Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cells.
Clin Exp Allergy
2009
19647862
Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber.
J Allergy Clin Immunol
2009
19183416
Standardization of allergen products: 1. Detailed characterization of GMP-produced recombinant Bet v 1.0101 as biological reference preparation.
Allergy
2009
19265114
Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.
J Immunol
2009
19226276
Production of native and modified recombinant Der p 1 molecules in tobacco plants.
Clin Exp Allergy
2009
17848808
IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model.
Int Arch Allergy Immunol
2008
18774396
Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells.
J Allergy Clin Immunol
2008
18644025
Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route.
Clin Exp Allergy
2008
18660382
Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes".
Blood
2008
18204276
Single cell assessment of allergen-specific T cell responses with MHC class II peptide tetramers: methodological aspects.
Int Arch Allergy Immunol
2008
18354173
Assessment of Bet v 1-specific CD4+ T cell responses in allergic and nonallergic individuals using MHC class II peptide tetramers.
J Immunol
2008
17207260
Suspension-cultured BY-2 tobacco cells produce and mature immunologically active house dust mite allergens.
Plant Biotechnol J
2007
18063445
A synthetic triacylated pseudo-dipeptide molecule promotes Th1/TReg immune responses and enhances tolerance induction via the sublingual route.
Vaccine
2007
17531296
Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation.
J Allergy Clin Immunol
2007
16701145
Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines.
Immunol Allergy Clin North Am
2006
17124785
Sublingual vaccines based on wild-type recombinant allergens.
Eur Ann Allergy Clin Immunol
2006
16409190
Immune mechanisms of allergen-specific sublingual immunotherapy.
Allergy
2006
12356679
Trypanosoma cruzi down-regulates lipopolysaccharide-induced MHC class I on human dendritic cells and impairs antigen presentation to specific CD8(+) T lymphocytes.
Int Immunol
2002
10417171
Trypanosoma cruzi infects human dendritic cells and prevents their maturation: inhibition of cytokines, HLA-DR, and costimulatory molecules.
Infect Immun
1999
1 - 30 of 30
Column Actions
Search
Recommended Authors
Lyndsey M Muehling
University of Virginia
Career Start Year
2016
Number of shared co-authors
1
Beatrice Dyring-Andersen
Herlev and Gentofte Hospital, University of Copenhagen
Career Start Year
2011
Number of shared co-authors
0
Jacob D Eccles
University of Illinois at Chicago
Career Start Year
2008
Number of shared co-authors
1
Kirstin Jansen
Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich
Career Start Year
2008
Number of shared co-authors
0
Kristina M Harris
University of California san francisco
Career Start Year
2006
Number of shared co-authors
2
Mingjian Fei
Genentech Inc.
Career Start Year
2005
Number of shared co-authors
0
Marc Veldhoen
Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa
Career Start Year
2005
Number of shared co-authors
0
Franklin R Toapanta
University of Maryland School of Medicine
Career Start Year
2004
Number of shared co-authors
0
Rachana Agrawal
University of Virginia School of Medicine
Career Start Year
2004
Number of shared co-authors
1
Jonathan L Linehan
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year
2004
Number of shared co-authors
0
Stacey N Harbour
University of Alabama at Birmingham
Career Start Year
2003
Number of shared co-authors
0
Nicolas Bouladoux
National Institute of Allergy and Infectious Diseases
Career Start Year
1999
Number of shared co-authors
0
Joshua D Milner
Columbia University
Career Start Year
1999
Number of shared co-authors
1
Michelle A Gill
University of Rochester Medical Center
Career Start Year
1999
Number of shared co-authors
0
Jane H Buckner
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year
1995
Number of shared co-authors
1
Francesca Fallarino
University of Perugia
Career Start Year
1995
Number of shared co-authors
0
Yasmine Belkaid
National Institute of Allergy and Infectious Diseases
Career Start Year
1994
Number of shared co-authors
0
Deborah Palliser
Albert Einstein College of Medicine
Career Start Year
1992
Number of shared co-authors
0
Judith A Woodfolk
University of Virginia School of Medicine
Career Start Year
1992
Number of shared co-authors
1
Lisa M Wheatley
National Institutes of Health
Career Start Year
1991
Number of shared co-authors
2
Bali Pulendran
Institute for Immunity, Stanford University School of Medicine, Stanford University
Career Start Year
1990
Number of shared co-authors
0
Gurjit K Khurana Hershey
Cincinnati Children's Hospital Medical Center
Career Start Year
1989
Number of shared co-authors
0
Frank Brombacher
University of Cape Town
Career Start Year
1989
Number of shared co-authors
0
Ursula Grohmann
University of Perugia
Career Start Year
1988
Number of shared co-authors
0
Clare Baecher-Allan
Brigham and Women's Hospital, Harvard Medical School
Career Start Year
1988
Number of shared co-authors
1
Casey T Weaver
University of Alabama at Birmingham
Career Start Year
1986
Number of shared co-authors
0
Alessandro Sette
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology
Career Start Year
1984
Number of shared co-authors
2
Penelope A Morel
University of Pittsburgh
Career Start Year
1982
Number of shared co-authors
0
Thomas A E Platts-Mills
University of Virginia
Career Start Year
1974
Number of shared co-authors
1
Paola Ricciardi-Castagnoli
A. Menarini Biomarkers Singapore Pte Ltd
Career Start Year
1973
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Philippe Moingeon
France French Academy of Pharmacy
Co-authored papers
28
Erik Wambre
Precision Immunology Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers
7
Julie A McMurry
University of Colorado - Anschutz Medical Campus
Co-authored papers
1
Leonard Moise
EpiVax Inc.
Co-authored papers
1
William W Kwok
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Co-authored papers
1
David Enard
University of Arizona
Co-authored papers
1
Anne S De Groot
University of Georgia
Co-authored papers
1
William D Martin
EpiVax Inc.
Co-authored papers
1
David W Scott
University of British Columbia
Co-authored papers
1
1 - 9